Search results
The American Macular Degeneration Foundation Showc | Newswise
Newswise· 5 days ago“Our goal is to advance the development of treatments, tools and usable information that improve the lives of those affected by AMD and, just as important, a sense of hope ...
Kyowa Kirin Will Present Pre-Clinical Data at the Association for Research in Vision and...
FOX21 Colorado Springs· 6 days agoAge-related macular degeneration (AMD) is a leading cause of severe vision loss for people aged 50 years and older in developed countries worldwide, with ...
Age-Related Macular Degeneration: Putting a Hole in Our World
WebMD· 4 days agoWhen we’re young, we take our macula for granted. At the center of our retina – the deepest layer of the eye that’s chock-full of photoreceptors and that confers color to our world – the macula ...
Earnings call: Lineage Cell Therapeutics reports positive OpRegen trial results
Investing.com· 4 days agoThe therapy showed an average gain in visual acuity, contrasting with the typical loss experienced...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 8 hours agoTinlarebant is Belite Bio’s orally administered tablet intended to slow disease progression in patients affected with Stargardt Disease (STGD1) and Geographic Atrophy (GA) in advanced Dry Age-related ...
Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX) to Post FY2028 Earnings of $0.16 Per Share, HC...
ETF DAILY NEWS· 5 hours agoLineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX – Free Report) – Investment analysts at HC Wainwright lowered their FY2028 earnings per share (EPS) estimates for shares of Lineage Cell Therapeutics ...
Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer...
WTNH-TV New Haven· 12 hours agoGLOW2 is the second Phase 3 study of tarcocimab in diabetic retinopathy in which all patients on...
For treating retinopathy of prematurity, research proves that ranibizumab is safe
Medical Xpress· 18 hours agoThe study, published in eClinicalMedicine, answers a longstanding concern about which is the safest,...
Adverum Biotechnologies Reports Q1 2024 Results: A Detailed Look at Financials and Pipeline Progress
GuruFocus.com via Yahoo Finance· 4 days agoIts flagship product, ADVM-022 (Ixo-vec), aims to revolutionize care for patients with wet age-related macular degeneration (AMD) by reducing the frequency ...
Telomir Pharmaceuticals sees breakthrough potential in Anti-Aging Treatment with Telomir 1
Proactive Investors· 7 days agoDrawing from his background in ophthalmology at Johns Hopkins, O'Donnell explained that the drug is...